Seahorse Bioscience Acquires BioProcessors; Raises Private Cash

Seahorse acquired the maker of the SimCell System, a fully integrated cell culture automation system used for selecting clones, optimizing media, and determining the best process conditions for protein manufacturing, for an undisclosed sum. It also raised $6 million in funding from VC investors.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.